Bijoy Hans Limited Issues Postal Ballot Notice for Name Change to Arvaya Healthcare
Bijoy Hans Limited has issued a comprehensive postal ballot notice seeking shareholder approval for multiple corporate restructuring initiatives including name change to Arvaya Healthcare Limited, enhanced financial authorizations of ₹200 crores, executive appointments with ₹10 lakh monthly remuneration, and capital structure expansion from ₹60 crores to ₹200 crores authorized share capital through electronic voting process.
*this image is generated using AI for illustrative purposes only.
Bijoy Hans Limited issued a comprehensive postal ballot notice on March 19, 2026, seeking shareholder approval for multiple corporate restructuring initiatives previously approved by the board of directors on March 17, 2026. The notice outlines nine special resolutions requiring member consent through electronic voting.
Corporate Name Change Process
The company is pursuing a strategic name change from "Bijoy Hans Limited" to "Arvaya Healthcare Limited" to better align with its healthcare business focus. Notably, the postal ballot includes withdrawal of a previously approved name "Arvaya Healthtech Limited" that was sanctioned at an extraordinary general meeting on February 25, 2026.
| Name Change Process: | Details |
|---|---|
| Current Name: | Bijoy Hans Limited |
| Previously Approved Name: | Arvaya Healthtech Limited (to be withdrawn) |
| Proposed New Name: | Arvaya Healthcare Limited |
| Regulatory Approval: | Ministry of Corporate Affairs approved |
Financial Authorization Enhancements
The postal ballot seeks approval for substantial increases in financial limits to support business expansion:
| Financial Authorizations: | Proposed Limits | Legal Framework |
|---|---|---|
| Borrowing Limits: | ₹200 crores | Section 180(1)(c) of Companies Act, 2013 |
| Loans, Guarantees & Investments: | ₹200 crores | Section 186 of Companies Act, 2013 |
| Related Party Transactions: | ₹100 crores | Section 185 of Companies Act, 2013 |
Leadership Structure Changes
Significant executive appointments and remuneration revisions require shareholder approval:
| Leadership Changes: | Details | Monthly Remuneration |
|---|---|---|
| Managing Director Kaushal Shah: | Remuneration revision | ₹10.00 lakhs |
| Salil Shetty: | Non-Executive to Executive Director & CEO | ₹10.00 lakhs |
| Tenure: | CEO appointment period | April 1, 2026 to March 31, 2031 |
Capital Structure Expansion
The company proposes fundamental changes to its authorized share capital structure:
| Capital Structure: | Current | Proposed |
|---|---|---|
| Authorized Share Capital: | ₹60 crores | ₹200 crores |
| Equity Shares: | 6 crore shares of ₹10 each | 20 crore shares of ₹10 each |
| Articles of Association: | Existing framework | Updated for Companies Act, 2013 compliance |
E-Voting Process and Timeline
The postal ballot will be conducted exclusively through electronic voting, with NSDL providing the e-voting platform. Mr. Chinmay Mohan Lele, Practicing Company Secretary (FCS 12351; CP: 28362), has been appointed as Scrutinizer to ensure fair and transparent proceedings.
| Voting Schedule: | Date & Time |
|---|---|
| Cut-off Date: | March 13, 2026 |
| E-voting Commencement: | March 21, 2026 at 9:00 AM IST |
| E-voting Conclusion: | April 19, 2026 at 5:00 PM IST |
| Result Declaration: | On or before April 21, 2026 |
The postal ballot notice has been sent electronically to shareholders whose email addresses are registered with the company's registrar, Maheshwari Datamatics Private Limited, and depositories NSDL and CDSL. Results will be uploaded on stock exchanges within two working days of conclusion and published on the company website at https://www.bijoyhans.net/ and NSDL's e-voting portal.
How will the significant increase in authorized share capital from ₹60 crores to ₹200 crores impact existing shareholders' ownership dilution in future fundraising rounds?
What specific healthcare sector acquisitions or expansion plans might justify the substantial ₹200 crore increase in borrowing and investment limits?
Will the leadership transition with Salil Shetty becoming CEO signal a strategic pivot in the company's healthcare business model or market focus?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
